Publications

Home » Publications
Export 13 results:
Filters: Author is Oldenburg, Catherine E and Keyword is Humans  [Clear All Filters]
2024
Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.
2022
Oldenburg CE, Hinterwirth A, Ourohiré M, Dah C, Ouédraogo M, Sie A, Boudo V, Chen C, Ruder K, Zhong L et al..  2022.  Gut Resistome after Antibiotics among Children with Uncomplicated Severe Acute Malnutrition: A Randomized Controlled Trial.. Am J Trop Med Hyg. 107(1):59-64.
2021
O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.
2020
Oldenburg CE, Doan T.  2020.  Azithromycin for severe COVID-19.. Lancet. 396(10256):936-937.
Digitale J, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Lebas E, Arzika AM, Glymour MMaria et al..  2020.  Gut Bacterial Diversity and Growth among Preschool Children in Burkina Faso.. Am J Trop Med Hyg. 103(6):2568-2573.
Oldenburg CE, Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Cummings SL, Zhong L, Chen C et al..  2020.  Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized, Controlled Trial.. Clin Infect Dis. 70(3):525-527.
Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.
Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Zhong L, Chen C, Lietman TM, Keenan JD et al..  2020.  Rapid Reduction of Species in the Gut Microbiome of Preschool Children after Oral Azithromycin: A Randomized Controlled Trial.. Am J Trop Med Hyg. 103(3):1266-1269.
Doan T, Hinterwirth A, Arzika AM, Worden L, Chen C, Zhong L, Oldenburg CE, Keenan JD, Lietman TM.  2020.  Reduction of Coronavirus Burden With Mass Azithromycin Distribution.. Clin Infect Dis. 71(16):2282-2284.
Oldenburg CE, Doan T.  2020.  Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.. Am J Trop Med Hyg. 102(6):1154-1155.
2019
Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.
Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.
Sie A, Bountogo M, Nebie E, Ouattara M, Coulibaly B, Bagagnan C, Zabre P, Lebas E, Brogdon J, Godwin WW et al..  2019.  Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.. BMJ Open. 9(9):e031162.